ISIN | LU2040176112 |
---|---|
Valor Number | 49405956 |
Bloomberg Global ID | |
Fund Name | Swisscanto (LU) Equity Fund Committed Europe Top Dividend CA |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | Swisscanto Fondsleitung AG |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund assets will be invested in an investment universe dedicated to companies with a high dividend yield and which have their registered office or conduct the majority of their business operations in the geographical region referred to in the name of the sub-fund. |
Peculiarities |
Current Price * | 131.43 EUR | 03.04.2025 |
---|---|---|
Previous Price * | 133.30 EUR | 02.04.2025 |
52 Week High * | 135.80 EUR | 19.03.2025 |
52 Week Low * | 116.74 EUR | 16.04.2024 |
NAV * | 131.43 EUR | 03.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 30,601,500 | |
Unit/Share Assets *** | 2,331,380 | |
Trading Information SIX |
YTD Performance | +6.93% |
31.12.2024 - 03.04.2025
31.12.2024 03.04.2025 |
---|---|---|
YTD Performance (in CHF) | +7.94% |
31.12.2024 - 03.04.2025
31.12.2024 03.04.2025 |
1 month | -2.05% |
03.03.2025 - 03.04.2025
03.03.2025 03.04.2025 |
3 months | +6.58% |
03.01.2025 - 03.04.2025
03.01.2025 03.04.2025 |
6 months | +4.06% |
03.10.2024 - 03.04.2025
03.10.2024 03.04.2025 |
1 year | +10.41% |
03.04.2024 - 03.04.2025
03.04.2024 03.04.2025 |
2 years | +18.85% |
03.04.2023 - 03.04.2025
03.04.2023 03.04.2025 |
3 years | +18.10% |
04.04.2022 - 03.04.2025
04.04.2022 03.04.2025 |
5 years | +76.29% |
03.04.2020 - 03.04.2025
03.04.2020 03.04.2025 |
Equity Participation Rate in % | 97.34 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Shell PLC | 5.10% | |
---|---|---|
Roche Holding AG | 3.90% | |
Allianz SE | 3.51% | |
Novartis AG Registered Shares | 3.22% | |
Swiss Re AG | 3.11% | |
GSK PLC | 3.05% | |
Zurich Insurance Group AG | 3.00% | |
AXA SA | 2.98% | |
Sanofi SA | 2.92% | |
BP PLC | 2.81% | |
Last data update | 28.02.2025 |
TER | 0.92% |
---|---|
TER date | 28.03.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 1.10% |
Ongoing Charges *** | 0.93% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |